RESUMEN
Effects of the GABA-CoA reductase inhibitor lovastatin and the ACE inhibitor captopril on the induction and growth of mammary gland tumors induced by N-methyl-N-nitrosourea in Wistar rats have been studied. It is established that lovastatin administered in a doze of 80 mg/kg two times a week exhibits anticarcinogenic activity, which is manifested by a significant decrease in the incidence of neoplasms and an increase in the survival lifetime in the experimental animals. Captopril administered in a doze of 50 mg/kg two times a week significantly decreased the tumor growth rate. The chemopreventive activity of these drugs can be due to their possible regulatory influence on the processes of cell proliferation, differentiation, neoangiogenesis, and apoptosis. The results of this investigation show good prospects for the further investigation of lovastatin and captopril as chemotherapeutic agents for the prophylaxis of mammary tumor.
Asunto(s)
Anticarcinógenos/uso terapéutico , Captopril/uso terapéutico , Lovastatina/uso terapéutico , Neoplasias Mamarias Experimentales/prevención & control , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Animales , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Femenino , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Neoplasias Mamarias Experimentales/inducido químicamente , Neoplasias Mamarias Experimentales/patología , Metilnitrosourea , Ratas , Ratas WistarRESUMEN
4,4'-diaminodiphenyl ether (dadpe) was injected subcutaneously (once a week) or given per orally (1-5 times a week) in rats in a dose of 25 mg/per rat and in mice of line CC57W in a dose of 5 mg/per mouse. Administration of the substance produced in mice and rats under study renal lesions of the nephrosis type with a nephritic component. In later stages of the experiment some rats showed adenomatous regeneration and formation of renal cysts, in one rat hypernephroid cancer of the kidney was observed. Tumors of different localizations were found in 44% of rats (in 7 of 16 animals), and in 57% of mice (in 8 of 14 animals) in experiments with peroral administration of the substance; in 18% of rats (in 7 of 39 animals) and in 33% of mice (in 3 of 9 animals) in experiments with subcutaneous injection of the substance. The results of the experiments have evidenced an insignificant blastomogenic action of 4,4'-diaminodiphenyl ether.
Asunto(s)
Compuestos de Aminobifenilo/análogos & derivados , Bencidinas/análogos & derivados , Neoplasias Experimentales/inducido químicamente , Adenocarcinoma/inducido químicamente , Administración Oral , Animales , Bencidinas/administración & dosificación , Femenino , Inyecciones Subcutáneas , Riñón/efectos de los fármacos , Neoplasias Renales/inducido químicamente , Leucemia Experimental/inducido químicamente , Masculino , Ratones , Ratones Endogámicos C57BL , Ratas , Factores de TiempoRESUMEN
C57W and SHR mice were given intraperitoneal injections of 100 or 300 mg/kg body weight glucuronic acid (in isotonic NaCl solution) 15-30 minutes prior to treatment with urethan, dibutylnitrosamine or 7,12-dimethyl-1,2-benzanthracene. This resulted in a lower carcinogenic effect on the lung and the incidence of lung adenoma was half that registered in the animals who had received a carcinogen only.
Asunto(s)
Carcinógenos/antagonistas & inhibidores , Glucuronatos/uso terapéutico , Neoplasias Pulmonares/inducido químicamente , 9,10-Dimetil-1,2-benzantraceno/antagonistas & inhibidores , Animales , Ácido Glucurónico , Neoplasias Pulmonares/prevención & control , Ratones , Nitrosaminas/antagonistas & inhibidores , Uretano/antagonistas & inhibidoresRESUMEN
It was shown in experiments on 186 mice that formation of tumors of the lung and fore-stomach induced by injection of sodium nitrite in combination with aminopyrine or methylurea is inhibited following treatment with ascorbic acid, hexamethylenetetramine or sodium metabisulfite.
Asunto(s)
Aminopirina/administración & dosificación , Ácido Ascórbico/uso terapéutico , Cocarcinogénesis , Neoplasias Pulmonares/inducido químicamente , Metenamina/uso terapéutico , Compuestos de Metilurea/administración & dosificación , Nitritos/administración & dosificación , Nitrito de Sodio/administración & dosificación , Neoplasias Gástricas/inducido químicamente , Sulfitos/uso terapéutico , Animales , Femenino , Neoplasias Pulmonares/prevención & control , Masculino , Ratones , Ratones Endogámicos , Neoplasias Gástricas/prevención & controlRESUMEN
Under study was the effect of phenobarbital, medinal and aminazine on the development of lung tumors in mice, as well as on the content of cytochrome P-450 in rat liver microsomes. Phenobarbital and medinal administration resulted in a 2-8 fold increase in cytochrome P-450 amount. Aminazine would reduce the latter but insignificantly. The number of urethan induced lung adenomas in mice was reduced by 64 per cent in phenobarbital exposure while medinal yielded only the decrease by 25-44 per cent. Aminazine failed to effect urethan carcinogenesis. Medinal would also suppress the development of DMBA induced lung tumors in mice by 34 per cent, but MC-by 50 per cent.
Asunto(s)
Antineoplásicos , Sistema Enzimático del Citocromo P-450/metabolismo , Neoplasias Pulmonares/prevención & control , Microsomas Hepáticos/enzimología , 9,10-Dimetil-1,2-benzantraceno , Adenoma/inducido químicamente , Adenoma/enzimología , Animales , Barbital/uso terapéutico , Clorpromazina/uso terapéutico , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/enzimología , Masculino , Metilcolantreno , Ratones , Ratones Endogámicos , Neoplasias Experimentales , Fenobarbital/uso terapéutico , UretanoRESUMEN
Rats were injected sarcolysin-H3 in a dose of 200 or 500 mC per rat. In animals sacrificed 30, 60 and 90 minutes following sarcolysin-H3 injection an increased radioactivity of DNA was noted that indicates binding of sarcolysin-H3 or its labelled derivatives to DNA. Guanine or quanosine-2', 3' monophosphate injected in animals decreased binding of sarcolysin-H3 to the rat liver DNA (maximum reduction of DNA radioactivity in 47%). In the experiments in vitro guanosine-2', 3' phosphate inhibited sarcolysin-H3 binding to DNA isolated from E. coli. A protective effect of quanine and guanosine-2', 3' phosphate with respect to DNA alkylation seems to be considerably conditioned by a competitive action of these nucleophils.
Asunto(s)
ADN/metabolismo , Nucleótidos de Guanina/farmacología , Guanina/farmacología , Hígado/metabolismo , Melfalán/metabolismo , Animales , Escherichia coli , Masculino , RatasRESUMEN
The authors have studied the effect of adenine, adenosine, guanosine, cytidine and cysteine on sarcolysine-3H binding to DNA in vivo (rat liver) an in vitro and DMNA-14C binding in vivo. It was shown that among the compounds under test adenine, adenosine and guanosine rendered a marked protective effect with relation to DNA alkylation, which is likely to be due to their nucleophilic properties.
Asunto(s)
Núcleo Celular/efectos de los fármacos , ADN/metabolismo , Dimetilnitrosamina/metabolismo , Melfalán/metabolismo , Animales , Radioisótopos de Carbono , Bovinos , Técnicas In Vitro , Hígado/efectos de los fármacos , Hígado/metabolismo , Unión Proteica/efectos de los fármacos , Ratas , TritioRESUMEN
The character of blastomogenic action of 7,12-dimethylbenz(a)anthracene on the stomach in its parenteral administration was studied on different lines of mice. Under the same conditions DMBA distribution was investigated in the proventriculus and gastric glandular tissues. In DMBA application on mice skin oin the dosage of 0.05 mg per animal in 0.1 ml of acetone proventricular tumors developed in 34% of mice of line CC57Br, in 10% of mice of line CC57W, and in 11% of mice of line C3HA, and in 19% of white nonpedigree mice. In intraperitoneal injection of DMBA in the dose of 0.5 mg per mouse in 0.2 ml of saline solution proventricular tumors appeared in 56% of CC57Br mice (in 9 of 16) and in one of five mice of CC57W line. Whereas, in application of DMBA onto mice skin in the dose of 0.5 mg per mouse in 0.1 ml of acetone the DMBA content in the proventriculus was 13 times higher than that in gastric glandular tissues.
Asunto(s)
9,10-Dimetil-1,2-benzantraceno , Benzo(a)Antracenos , Carcinoma de Células Escamosas/inducido químicamente , Papiloma/inducido químicamente , Neoplasias Gástricas/inducido químicamente , 9,10-Dimetil-1,2-benzantraceno/análisis , Animales , Inyecciones Intraperitoneales , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos , Neoplasias Experimentales/inducido químicamente , Absorción Cutánea , Especificidad de la Especie , Estómago/análisisRESUMEN
The character of blastomogenic action of 7,12-dimethylbenz(a)anthracene on the stomach in its parenteral administration was studied on different lines of mice. Under the same conditions DMBA distribution was investigated in the proventriculus and gastric glandular tissues. In DMBA application on mice skin in the dosage of 0.5 mg per animal in 0.1 ml of acetone proventricular tumors developed in 34% of mice of line CC57Br, in 10% of mice of line CC57W, and in 11% of mice of line C3HA, and in 19% of white nonpedigree mice. In intraperitoneal injection of DMBA in the dose of 0.5 mg per mouse in 0.2 ml of saline solution proventricular tumors appeared in 56% of CC57Br mice (in 9 of 16) and in one of five mice of CC57W line. Whereas, in application of DMBA onto mice skin in the dose of 0.5 mg per mouse in 0.1 ml of acetone the DMBA content in the proventriculus was 13 times higher than that in gastric glandular tissues.
Asunto(s)
Enfermedades Fetales/inducido químicamente , Enfermedades Pulmonares/inducido químicamente , Metilnitrosourea/toxicidad , Compuestos de Nitrosourea/toxicidad , Femenino , Humanos , Hiperplasia/inducido químicamente , Pulmón/embriología , Mitosis , Necrosis/inducido químicamente , Técnicas de Cultivo de Órganos , Especificidad de Órganos , Embarazo , Factores de TiempoRESUMEN
It is studied the influence of two types of experimental diets on rats origin mammary tumors. The first diet was enriched by pig's fat and 2nd diet contained soybean protein and induced N-nitrozo-N-methylurea (MNM). The tumors of rat's mamma were induced by intramammary injections of N-nitrozo-N-methylurea in area of the 2nd left mamma in dose 2.5 mg per rat once a week during 5 weeks. The rats of control group were not exposed to any additional influences except for a carcinogenic one. The rats of first and second subgroup were fed with lard (50 mg/kg) and soybean protein (200 mg/kg) during 30 weeks. It was shown that lard evinced cocarcinnogenic action on the origin of mammary tumors to stimulating their growth and development while the soybean protein considerably reduced frequency of mammary tumors and slowed the time of their appearance.
Asunto(s)
Grasas de la Dieta/efectos adversos , Neoplasias Mamarias Experimentales/dietoterapia , Proteínas de Soja/uso terapéutico , Animales , Cocarcinogénesis , Grasas de la Dieta/administración & dosificación , Femenino , Neoplasias Mamarias Experimentales/inducido químicamente , Neoplasias Mamarias Experimentales/patología , Metilnitrosourea , Ratas , Proteínas de Soja/administración & dosificación , Factores de TiempoAsunto(s)
Compuestos Azo/metabolismo , ADN/biosíntesis , ARN/biosíntesis , Animales , Compuestos Azo/farmacología , ADN/metabolismo , Femenino , Hepatectomía , Hígado/efectos de los fármacos , Hígado/metabolismo , Ratones , Mitosis , Proteínas/metabolismo , ARN/metabolismo , Timidina , Tolueno/metabolismo , Tolueno/farmacología , Toluidinas/metabolismo , Toluidinas/farmacología , Tritio , Vejiga Urinaria/efectos de los fármacosAsunto(s)
Carcinógenos/farmacología , Hidroxiácidos/farmacología , Indoles/farmacología , Triptófano/farmacología , ortoaminobenzoatos/farmacología , Adenocarcinoma/inducido químicamente , Adenofibroma/inducido químicamente , Animales , Cistoadenoma/inducido químicamente , Femenino , Hidroxiácidos/administración & dosificación , Inyecciones Subcutáneas , Neoplasias Renales/inducido químicamente , Leiomiosarcoma/inducido químicamente , Leucemia Experimental/inducido químicamente , Neoplasias Hepáticas/inducido químicamente , Neoplasias Pulmonares/inducido químicamente , Linfoma de Células B Grandes Difuso/inducido químicamente , Masculino , Neoplasias Mamarias Experimentales/inducido químicamente , Ratones , Ratones Endogámicos C57BL , Metástasis de la Neoplasia , Neoplasias Experimentales/inducido químicamente , Pólipos/inducido químicamente , Ratas , Factores de Tiempo , Triptófano/administración & dosificación , Neoplasias Uterinas/inducido químicamente , ortoaminobenzoatos/administración & dosificaciónAsunto(s)
Antioxidantes/uso terapéutico , Tetracloruro de Carbono/uso terapéutico , Neoplasias Experimentales/tratamiento farmacológico , Uretano/antagonistas & inhibidores , Adenoma/inducido químicamente , Adenoma/tratamiento farmacológico , Administración Oral , Animales , Transformación Celular Neoplásica/efectos de los fármacos , Depresión Química , Relación Dosis-Respuesta a Droga , Inyecciones Intraperitoneales , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/tratamiento farmacológico , Ratones , Ratones Endogámicos C57BL , Neoplasias Experimentales/inducido químicamente , Fenoles/uso terapéutico , Fenilendiaminas/uso terapéutico , Proadifeno/uso terapéutico , Factores de Tiempo , Uretano/farmacología , Vitamina E/uso terapéuticoAsunto(s)
Antioxidantes/uso terapéutico , Compuestos Azo , Carcinógenos , Neoplasias Hepáticas/prevención & control , Neoplasias Experimentales/prevención & control , Animales , Cresoles/uso terapéutico , Femenino , Neoplasias Hepáticas/inducido químicamente , Ratones , Ratones Endogámicos , Naftalenos/uso terapéutico , Neoplasias Experimentales/inducido químicamente , Fenilendiaminas/uso terapéutico , Sulfuros/uso terapéutico , Tolueno , ToluidinasAsunto(s)
Butilaminas/farmacología , Nitrosaminas/farmacología , Neoplasias de la Vejiga Urinaria/inducido químicamente , Adenocarcinoma/inducido químicamente , Adenocarcinoma/patología , Animales , Carcinoma Hepatocelular/inducido químicamente , Carcinoma Hepatocelular/patología , Neoplasias Esofágicas/inducido químicamente , Neoplasias Esofágicas/patología , Femenino , Inyecciones Subcutáneas , Neoplasias Hepáticas/inducido químicamente , Neoplasias Hepáticas/patología , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/patología , Masculino , Papiloma/inducido químicamente , Papiloma/patología , Ratas , Factores de Tiempo , Neoplasias de la Vejiga Urinaria/patologíaAsunto(s)
Neoplasias Pulmonares/prevención & control , Adulto , Contaminantes Atmosféricos/efectos adversos , Femenino , Humanos , Neoplasias Pulmonares/etiología , Neoplasias Pulmonares/mortalidad , Masculino , Persona de Mediana Edad , Enfermedades Profesionales/etiología , Enfermedades Profesionales/prevención & control , Plantas Tóxicas , Riesgo , Factores Sexuales , Humo/análisis , Prevención del Hábito de Fumar , Nicotiana/análisis , Tabaquismo/complicaciones , Tabaquismo/mortalidadRESUMEN
The effects of nonsteroid antiinflammatory drugs (acetylsalicylic acid and celecoxib) on N-nitrosodiethylamine-induced carcinogenesis in the liver and esophagus were studied in rats. The inhibitory effect of celecoxib on carcinogenesis was more pronounced (in comparison with acetylsalicylic acid), which manifested in a significantly decreased incidence of neoplastic changes in the liver tissue (from 91.7 to 65.2%), number of tumors in the esophagus (from 4.13 to 2.61 tumor/rat), and in delayed malignization in the liver and esophagus. The incidence of erosions and ulcers of the gastric mucosa was significantly lower after celecoxib treatment. These data indicate that celecoxib inhibits N-nitrosodiethylamine-induced carcinogenesis in the liver and esophagus.
Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Anticarcinógenos/farmacología , Aspirina/farmacología , Dietilnitrosamina , Neoplasias Esofágicas/prevención & control , Neoplasias Hepáticas/prevención & control , Pirazoles/farmacología , Sulfonamidas/farmacología , Animales , Celecoxib , Neoplasias Esofágicas/inducido químicamente , Neoplasias Esofágicas/patología , Neoplasias Hepáticas/inducido químicamente , Neoplasias Hepáticas/patología , Masculino , Ratas , Ratas WistarRESUMEN
Embryos died and a teratogenic effect followed combined intragastric administration of methylurea (MU) and sodium nitrite (SN) to rats on the 9th day of pregnancy; this was caused by the endogenous synthesis of nitroso-methylurea which produced a pathogenic action. Ascorbic acid and urotropine completely blocked the possibility of manifestation of the embryotoxic and teratogenic effect occuring after combined administration of MU and SN. Sodium sulfomate decreased the embryotoxic and partially the teratogenic effect considerably, whereas urea failed to prevent the expression of the harmful effect of MU and SN on the embryo.